Organization
Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University and the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
1 abstract
Abstract
CT103A, a novel fully human BCMA-targeting CAR-T cells, in patients with relapsed/refractory multiple myeloma: Updated results of phase 1b/2 study (FUMANBA-1).Org: Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science, Wuhan, China, Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University and the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China, Department of Hematology, The First Affliated Hospital, Zhejiang University;, Hangzhou, China, Jiangsu Province Hospital, Nanjing, China, Department of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China,